Gilead 427-4024..A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Primary Biliary Cholangitis Without Cirrhosis
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Gilead Sciences, Inc.
Start Date
February 21, 2017
End Date
October 12, 2019
Administered By
Medicine, Gastroenterology
Awarded By
Gilead Sciences, Inc.
Start Date
February 21, 2017
End Date
October 12, 2019